Typhim Vi (Sanofi Pasteur Inc.)


Welcome to the PulseAid listing for the Typhim Vi drug offered from Sanofi Pasteur Inc.. This Inactivated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Vaccines, Typhoid [Chemical/Ingredient],Vi polysaccharide vaccine, typhoid [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: Sanofi Pasteur Inc.
NON-PROPRIETARY NAME: SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
SUBSTANCE NAME: SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Inactivated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Vaccines, Typhoid [Chemical/Ingredient],Vi polysaccharide vaccine, typhoid [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1994-11-28
END MARKETING DATE: 0000-00-00


Typhim Vi VACCINE Details:

Item DescriptionTyphim Vi from Sanofi Pasteur Inc.
LABELER NAME: Sanofi Pasteur Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(ug/.5mL)
START MARKETING DATE: 1994-11-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49281-790_47d28f8b-8293-4e16-a084-cc7936faa9b7
PRODUCT NDC: 49281-790
APPLICATION NUMBER: BLA103936

Other SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanofi Pasteur Inc.Typhim Vi